Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Carcinoma, Non-Small-Cell Lung × entrectinib × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Uveal Melanoma 1 Solid Tumor 1 Noonan Syndrome 6 1 Neoplasms, Unknown Primary 1 Melanoma 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 200 Pemetrexed 179 Paclitaxel 140 Cisplatin 130 Erlotinib Hydrochloride 122 pembrolizumab 115 Docetaxel 112 Gemcitabine 77 Bevacizumab 74 Nivolumab 63 Radiotherapy 57 osimertinib 32 Afatinib 32 130-nm albumin-bound paclitaxel 31 Radiosurgery 30 Cetuximab 29 durvalumab 27 atezolizumab 27 Albumin-Bound Paclitaxel 27 Gefitinib 26 Ipilimumab 25 Taxes 21 Vinorelbine 18 Crizotinib 18 Etoposide 17 Cyclophosphamide 16 Sorafenib 14 Radiation 13 Magnetic Resonance Spectroscopy 13 Drug Therapy 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05834348 2025-03-30

DELINOR

Pfizer

5,279 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡